Sign In
Buy OGN
$13.56
+0 (+0%)
At Close: Aug 04, 2026
Organon (OGN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
11:31am, Thursday, 13'th Feb 2025
The headline numbers for Organon (OGN) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estima
Organon (OGN) Q4 Earnings and Revenues Beat Estimates
09:46am, Thursday, 13'th Feb 2025
Organon (OGN) came out with quarterly earnings of $0.90 per share, beating the Zacks Consensus Estimate of $0.86 per share. This compares to earnings of $0.88 per share a year ago.
Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2024
07:30am, Thursday, 13'th Feb 2025
JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon announces Q4 2024 and Full Year 2024 earnings results, ending December 31, 2024.
Why Organon (OGN) Dipped More Than Broader Market Today
06:50pm, Friday, 07'th Feb 2025
Organon (OGN) concluded the recent trading session at $14.62, signifying a -1.81% move from its prior day's close.
Organon (OGN) Rises Higher Than Market: Key Facts
06:56pm, Thursday, 30'th Jan 2025
The latest trading day saw Organon (OGN) settling at $15.97, representing a +0.82% change from its previous close.
Organon (OGN) Increases Despite Market Slip: Here's What You Need to Know
07:06pm, Monday, 27'th Jan 2025
Organon (OGN) closed at $16.26 in the latest trading session, marking a +1.82% move from the prior day.
Organon To Report Fourth Quarter and Full Year 2024 Results and Host Conference Call on February 13, 2025
07:30am, Thursday, 23'rd Jan 2025
JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon To Report Fourth Quarter and Full Year 2024 Results and Host Conference Call on February 13, 2025.
Organon (OGN) Surpasses Market Returns: Some Facts Worth Knowing
07:05pm, Tuesday, 21'st Jan 2025
Organon (OGN) closed the most recent trading day at $15.88, moving +0.89% from the previous trading session.
Organon: A Tricky 2025 Awaits, But I'm Happy With A >7% Dividend Yield
01:03pm, Friday, 17'th Jan 2025
Organon has faced significant price volatility and underperformance since its spin-off from Merck, with shares down ~50% since 2021. Key products like Nexplanon and VTAMA are crucial for future growth
Organon & Co. (OGN) JPMorgan Annual Healthcare Conference - (Transcript)
09:38pm, Monday, 13'th Jan 2025
Organon & Co. (NYSE:OGN ) JPMorgan Annual Healthcare Conference Call January 13, 2025 6:45 PM ET Company Participants Kevin Ali - Chief Executive Officer Matthew Walsh - Chief Financial Officer Confer
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know
10:01am, Wednesday, 01'st Jan 2025
Recently, Zacks.com users have been paying close attention to Organon (OGN). This makes it worthwhile to examine what the stock has in store.
Want $2,000 in Annual Dividends? Invest $11,000 in Each of These 3 Stocks.
07:55am, Wednesday, 01'st Jan 2025
Investing in dividend stocks can be an excellent way to boost your income each year. But the challenge can be generating a good return while keeping your risk low.
Organon (OGN) Ascends While Market Falls: Some Facts to Note
06:56pm, Friday, 27'th Dec 2024
Organon (OGN) closed at $15.06 in the latest trading session, marking a +0.74% move from the prior day.
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know
10:00am, Friday, 20'th Dec 2024
Organon (OGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Organon To Present at the 43rd Annual J.P. Morgan Healthcare Conference
07:30am, Thursday, 19'th Dec 2024
JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon CEO Kevin Ali and CFO Matthew Walsh to present in a fireside chat at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13th.
